Abstract

Purpose/Objectives(s)Salivary gland tumors are a rare, histologically heterogeneous group of tumors. The distinction between malignant and benign tumors of the parotid gland is clinically important. This study aims to develop and evaluate a deep-learning network for diagnosing parotid gland tumors via the deep learning of MR images.Materials/MethodsTwo hundred thirty-three patients with parotid gland tumors were enrolled in this study. Histology results were available for all tumors. All patients underwent MRI scans, including T1-weighted, CE-T1-weighted and T2-weighted imaging series. The parotid glands and tumors were segmented on all three MR image series by a radiologist with 10 years of clinical experience. A total of 3791 parotid gland region images were cropped from the MR images. A label (pleomorphic adenoma and Warthin tumor, malignant tumor or free of tumor), which was based on histology results, was assigned to each image. To train the deep-learning model, these data were randomly divided into a training dataset (90%, comprising 3035 MR images from 212 patients: 714 pleomorphic adenoma images, 558 Warthin tumor images, 861 malignant tumor images, and 902 images free of tumor) and a validation dataset (10%, comprising 275 images from 21 patients: 57 pleomorphic adenoma images, 36 Warthin tumor images, 93 malignant tumor images, and 89 images free of tumor). A modified ResNet model was developed to classify these images. The input images were resized to 224x224 pixels, including four channels (T1-weighted tumor images only, T2-weighted tumor images only, CE-T1-weighted tumor images only and parotid gland images). Random image flipping and contrast adjustment were used for data enhancement. The model was trained for 1200 epochs with a learning rate of 1e-6, and the Adam optimizer was implemented. It took approximately 2 hours to complete the whole training procedure. The whole program was developed with PyTorch (version 1.2).ResultsThe model accuracy with the training dataset was 92.94% (95% CI [0.91, 0.93]). The micro-AUC was 0.98. The experimental results showed that the accuracy of the final algorithm in the diagnosis and staging of parotid cancer was 82.18% (95% CI [0.77, 0.86]). The micro-AUC was 0.93.ConclusionThe proposed model may be used to assist clinicians in the diagnosis of parotid tumors. However, future larger-scale multicenter studies are required for full validation.

Highlights

  • Parotid gland tumors are rare tumors, accounting for approximately 5% of head and neck tumors, and approximately 75% of them are benign

  • This study aims to develop a system to act as an intelligent assistant in medical image diagnosis based on deep-learning technology and to design a model for predicting parotid gland tumors

  • Pairs of MR series were integrated into the different image channels for training the model in (d-f), and all three MR series were used for the image channels in (g)

Read more

Summary

Introduction

Parotid gland tumors are rare tumors, accounting for approximately 5% of head and neck tumors, and approximately 75% of them are benign. The most common types of parotid gland benign tumors are pleomorphic adenomas and Warthin tumors [1, 2]. The preoperative diagnosis of benign and malignant tumors of the parotid gland is of great clinical significance and can have an important impact on surgical planning. The choice of surgical procedure depends on the histological type of the tumor. 5% to 10% of pleomorphic adenomas have a risk of malignant transformation and a high risk of recurrence, and radical surgery is usually used to treat them. The malignant transformation of Warthin tumors is extremely rare, occurring for only 0.3% of patients. Tumor removal or conservative observation is recommended in clinical practice to avoid the risk of facial nerve injury due to surgery [3]. Malignant tumors of the parotid gland request extensive resection [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call